{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-01-19T12:28:39.433430+00:00",
  "news": [
    {
      "title": "Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijAFBVV95cUxPWDRSd0xMTFdtYWxxNlRxUkRpMzNTTndHNlVRSFdZN0FhakJ4dFZVNk9zenQ4MW5UZzkySHVESTR5RFpyVFZBRjZ6SnpfQm94SjdTby1jaVo1LUFFczFuS3M1dU5ua240NEdLR0hvX3Zhd1VJa19rTE5uSGJiYTRDLTJWNWtkV3NsMV9qag?oc=5\" target=\"_blank\">Does Vertex Pharmaceuticals (VRTX) Share Price Reflect Its Long Term Growth Potential?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2026-01-09T08:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Stock Slid 5% This Week. Here’s What Changed - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNOUhDbC1aTHJYVDQzaGhCUWp2eFg0bTB2TWFqaDVhYklmVVZTQm00cUxKVVhUaVBPZ1JJOFpiVDIzM3VPMnJXVjFQcnFaMDBMZmNPNzlwOFRNQUJCdXVyZ1J0QzVTcmM4eTFlVkJUb3NsRmExakd4YWdEOVdqQ1dlbHVmSzJXampmQjFXNTNsWjE4a2l4?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilAFBVV95cUxNOUhDbC1aTHJYVDQzaGhCUWp2eFg0bTB2TWFqaDVhYklmVVZTQm00cUxKVVhUaVBPZ1JJOFpiVDIzM3VPMnJXVjFQcnFaMDBMZmNPNzlwOFRNQUJCdXVyZ1J0QzVTcmM4eTFlVkJUb3NsRmExakd4YWdEOVdqQ1dlbHVmSzJXampmQjFXNTNsWjE4a2l4?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock Slid 5% This Week. Here’s What Changed</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2026-01-18T19:11:17+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPMVFfeWp6Wk1UcFo1cXZHaVd1TC1XZTFqZm1pQVptSWExd2lmdTg4M0ZDWm1iVXlYUERwcmpXZDFTc0hhTjJzMi1ZWGVQVDMwamwzc1dEWXBac0h1NHZadWp2LWdOT042bXhLeGx1ajdhR1M3Z3B2MEN0SUNjaU5fU0VfSnVISFU5eERuZzBHbWFVam9hRmx2Nldn?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMVFfeWp6Wk1UcFo1cXZHaVd1TC1XZTFqZm1pQVptSWExd2lmdTg4M0ZDWm1iVXlYUERwcmpXZDFTc0hhTjJzMi1ZWGVQVDMwamwzc1dEWXBac0h1NHZadWp2LWdOT042bXhLeGx1ajdhR1M3Z3B2MEN0SUNjaU5fU0VfSnVISFU5eERuZzBHbWFVam9hRmx2Nldn?oc=5\" target=\"_blank\">Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-01-15T23:00:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "What Vertex Pharmaceuticals (VRTX)'s Q3 Results and 2026 Pipeline Plans Mean For Shareholders - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">What Vertex Pharmaceuticals (VRTX)'s Q3 Results and 2026 Pipeline Plans Mean For Shareholders</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-01-17T13:49:35+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Here's what to expect from Vertex Pharmaceuticals' next earnings report - MSN",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNZXBlbnVXQmFLMUlwVGZObG1CSjlmdUNuVjBOR0Rqamt5eUtvQ1ZBb1JxakIwZ1ZaLTNjTnNmY2NMb1FHV3kyUU5mRkkwWWY5TWs1VG9aSXU3VUNKeXA1Z2w0eE5NQlJjWXlPOGJUb003dm5Ua1NiSkwycjc5UElnZXQyVTU3eGtRWkhCMWpUU2o5ZEIzbU05eGswdFREN3R5M1FKODQtUXNUbEc2YkFLY0xseXNONjlVN3lhZ0F3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNZXBlbnVXQmFLMUlwVGZObG1CSjlmdUNuVjBOR0Rqamt5eUtvQ1ZBb1JxakIwZ1ZaLTNjTnNmY2NMb1FHV3kyUU5mRkkwWWY5TWs1VG9aSXU3VUNKeXA1Z2w0eE5NQlJjWXlPOGJUb003dm5Ua1NiSkwycjc5UElnZXQyVTU3eGtRWkhCMWpUU2o5ZEIzbU05eGswdFREN3R5M1FKODQtUXNUbEc2YkFLY0xseXNONjlVN3lhZ0F3?oc=5\" target=\"_blank\">Here's what to expect from Vertex Pharmaceuticals' next earnings report</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MSN</font>",
      "published": "2026-01-14T13:41:41+00:00",
      "source": "MSN"
    },
    {
      "title": "Working at Vertex - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Working at Vertex</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOeGRYamhHdDBSU3dWRC1oYjVNRVZBNTVZUVJ4aFJNNDltLW9QQ3NVRFZBVGxOdWhhSEZqYWU1T0VtVDVaQWNZQ2V6Qm0wd040eWVHU3N0MlA5akdJNUFFdlNWc1ZUT29rdDQ2ZGdQRjBET3RaNDFjekQxcHltYWh6TE4wcHRTMThyaUFEWDdQY1g2bDN3X25z?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOeGRYamhHdDBSU3dWRC1oYjVNRVZBNTVZUVJ4aFJNNDltLW9QQ3NVRFZBVGxOdWhhSEZqYWU1T0VtVDVaQWNZQ2V6Qm0wd040eWVHU3N0MlA5akdJNUFFdlNWc1ZUT29rdDQ2ZGdQRjBET3RaNDFjekQxcHltYWh6TE4wcHRTMThyaUFEWDdQY1g2bDN3X25z?oc=5\" target=\"_blank\">Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-01-14T16:15:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals - Time Magazine",
      "link": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQVkY3MnJaQ3p3Mk5LZGVBRXhDY0ZmaF9CS21MZWJSb01RRTNUN0JHUE9lTGRrckh6QnkxUGhXcm1yNk81WmM5aVdxZVdTdEFTMTBaN0E0MndpNHRLWjBJd2RrZ09JT3ZDaE04d21ucmVkcnl4aGFIcFlaN1QxcGtiT1lYQ2ppX202b2pr?oc=5\" target=\"_blank\">TIME100 Most Influential Companies 2025: Vertex Pharmaceuticals</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Time Magazine</font>",
      "published": "2025-06-26T07:00:00+00:00",
      "source": "Time Magazine"
    }
  ],
  "product_launches": [
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    },
    {
      "title": "Vertex’s New Products Dim as Analysts Eye Kidney Portfolio - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilgFBVV95cUxObHk5T3lvemFXaFY4LXUwYkNCRHBBNk1KQ1gwVFZ5Wmw2RW4xTEpWcXFoZ3YtaXJUUWd3c0Z3U0xnSkU3Q0VHUkhqVjh1cTJKME9FY0kzSDRGN2pIaWh5MDlyUVU3OHY0WEFCRHpnaXdEUkFZTWRxeWdvQWU1MVBBZ0FNRXZKLU45RUFQb2F2UmRjTmw2UGc?oc=5\" target=\"_blank\">Vertex’s New Products Dim as Analysts Eye Kidney Portfolio</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Vertex tops estimates on cystic fibrosis treatment strength, new products - Reuters",
      "link": "https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQV1RfcWFhZlB4RnlGTUNfYlJTOEFKaHREZHlEeV9GVHpnaW1zRDliVlMtX3dWdjZkS2RNRWhZaXc0NmdVcW10bVhmQV9NNlh3b3IwckhEME9rTFlIci1hRDF4RlFzRWprOWFTdjlVV1d4dVpIaVFGWXBiWF9tbnJmcFEydUxiNDF1TVJfLTI4QmtvcnIwWVhYd3hNTno2aFhpZF9WNFZjX3lJLVVsNjZfcWZOVTVzU2lXYzV1cmw0bDRpTUFiWjJLUElvRk15d1RKLWJnQy10MmU?oc=5\" target=\"_blank\">Vertex tops estimates on cystic fibrosis treatment strength, new products</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-08-04T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-01-16",
      "close": 441.3599853515625
    },
    "history": [
      {
        "date": "2026-01-08",
        "close": 469.67999267578125
      },
      {
        "date": "2026-01-09",
        "close": 463.8599853515625
      },
      {
        "date": "2026-01-12",
        "close": 460.5899963378906
      },
      {
        "date": "2026-01-13",
        "close": 454.6700134277344
      },
      {
        "date": "2026-01-14",
        "close": 449.5299987792969
      },
      {
        "date": "2026-01-15",
        "close": 438.9200134277344
      },
      {
        "date": "2026-01-16",
        "close": 441.3599853515625
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}